Shared molecular biomarkers and therapeutic targets in rheumatoid arthritis and osteoarthritis: Focus on EIF3B, KHSRP, NCL, PDCD1LG2, and SLC25A37.

QN-165 - Qualigen Therap

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/40592131

Chengguang Wei; Dalang Fang; Hui Li; Shuliang Hua; Tingyuan Zhang; Zhenxue Long

Jul 2, 2025